Sandwalk BioVentures and CosmosID Launch Joint GRAS Genomic Reporting Service
Sandwalk BioVentures and CosmosID Launch Joint GRAS Genomic Reporting Service News provided by Share this article Share this article MADRID, Spain and ROCKVILLE, Md., June 3, 2021 /PRNewswire/ -- Sandwalk BioVentures and CosmosID today announced the launch of a new joint service offering for Generally-Recognized As Safe (GRAS) regulatory genomic reporting for the Probiotics market in the USA. By combining CosmosID's end-to-end microbial genomics infrastructure with Sandwalk's regulatory experience and expertise, developers of the next generation of probiotics will now have access to an optim...
Source: prnewswire.com